Tuesday, September 21, 2010

Still a long wait for HIV-approved protective gel

via South African Medical Journal, by Chris Bateman

June 2013 – that’s the ‘realistic’ date by which vulnerable South African women can expect to begin using an officially approved vaginal microbicide gel that would provide them with an unprecedented tool to protect themselves from HIV infection. This is the belief of biochemist and epidemiologist, Dr Quarraisha Abdool Karim, who, together with her clinician and fellow epidemiologist husband, Professor Salim Abdool Karim, led the now world-renowned ‘proof of concept’ trial of tenofovir vaginal gel to prevent HIV infection in women. In a 3-year study of 889 women in both rural and urban KwaZulu-Natal, they demonstrated a 39% reduction in HIV infection and a 51% reduction in genital herpes infection among women who used the gel (containing 1% of the antiretroviral (ARV), tenofovir).

Read more

To read even more on this subject see the IRMA blog from 7/27/10

No comments:

Related Posts Plugin for WordPress, Blogger...